COVID-19 reinfection in a patient with a serious mental illness within a long-term inpatient psychiatric care hospital
| Autor: | Tiffany L Gordon, Amy Magdalany, Kelly Holladay, Brianna Englett |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
2019-20 coronavirus outbreak Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Case Reports inpatient reinfection antibody Medicine Pharmacology (medical) General Pharmacology Toxicology and Pharmaceutics hospital Psychiatry long-term SMI Transmission (medicine) business.industry SARS-CoV-2 COVID-19 Mental illness medicine.disease immunity psychiatry schizophrenia Neuropsychology and Physiological Psychology Schizophrenia serious mental illness Neurology (clinical) business congregate setting |
| Zdroj: | The Mental Health Clinician |
| ISSN: | 2168-9709 |
| Popis: | There is an increasing number of case reports of COVID-19 reinfection. The mechanism of reinfection is poorly understood and evolving. Prevention of the transmission of severe acute respiratory syndrome coronavirus 2 for those with a serious mental illness (SMI) living in a congregate setting presents unique challenges. In this case report, we describe an individual with an SMI in a long-term inpatient psychiatric care hospital who was initially diagnosed in June 2020 with COVID-19 infection via a polymerase chain reaction test. Approximately 6 months later, the patient presented with a COVID-19 reinfection and more severe COVID-like symptoms. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|